Burns McClellan’s IR and PR teams have vast experience developing
and communicating the stories of private and public life science companies to
their target audiences. Our staff of professionals have diverse backgrounds
in science, clinical development, regulatory affairs, equity research and
investing, banking, management consulting, and marketing/media and corporate
communications, providing a broad perspective to address our clients’ needs.

We work with companies that:

• Specialize in key life sciences sectors, with a focus on innovative
  therapeutics, including diagnostics and medical devices.
• Focus in diverse therapeutic areas including oncology,
  orphan/genetic diseases, ophthalmology, cardiovascular disease, CNS diseases
  and disorders, immunology, and infectious diseases.
• Leverage a variety of technology platforms including small
  molecules, biologics, cell therapies, gene therapies and nucleic acid
  platforms, transplantation technologies, drug delivery technologies, and
  preventive and therapeutic vaccines.

Our team
understands that each therapeutic space is unique. We leverage our robust
industry and sector knowledge to craft a compelling investment thesis and
strategic plan that helps position our clients as innovators in their
respective areas of therapeutic focus.